Do you want to read an article? Please log in or register.
Preventing COPD readmissions under the Hospital Readmissions Reduction Program: How far have we come?
COPD
Related content
Pneumonia
Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia
JAMA.
Wadhera RK, Joynt Maddox KE, Wasfy JH, Haneuse S, Shen C, Yeh RW
doi: 10.1001/jama.2018.19232.
RECOMMENDED
Further Publications
Readmissions Reduction Program, Mortality and Readmissions for Chronic Obstructive Pulmonary Disease
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Am J Respir Crit Care Med.
Puebla Neira DA, Hsu ES, Kuo YF, Ottenbacher KJ, Sharma G
doi: 10.1164/rccm.202002-0310OC.
RECOMMENDED
AsthmaCOPD
Risk factors and associated outcomes of hospital readmission in COPD: A systematic review
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Njoku CM, Alqahtani JS, Wimmer BC, Peterson GM, Kinsman L, Hurst JR, Bereznicki BJ
doi: 10.1016/j.rmed.2020.105988
RECOMMENDED
COPD
Treatment failure and hospital readmissions in severe COPD exacerbations treated with azithromycin versus placebo - a post-hoc analysis of the BACE randomized controlled trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res.
Vermeersch K, Belmans A, Bogaerts K, Gyselinck I, Cardinaels N, Gabrovska M, Aumann J, Demedts IK, Corhay JL, Marchand E, Slabbynck H, Haenebalcke C, Vermeersch S, Verleden GM, Troosters T, Ninane V, Brusselle GG, Janssens W, BACE trial investigators.
doi: 10.1186/s12931-019-1208-6.
COPD
Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial
JAMA.
Murphy PB, Rehal S, Arbane G, Bourke S, Calverley PMA, Crook AM, Dowson L, Duffy N, Gibson GJ, Hughes PD, Hurst JR, Lewis KE, Mukherjee R, Nickol A, Oscroft N, Patout M, Pepperell J, Smith I, Stradling JR, Wedzicha JA, Polkey MI, Elliott MW, Hart N
doi: 10.1001/jama.2017.4451.
COPD
Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
Respir Res.
Leitao Filho FS, Ra SW, Mattman A, Schellenberg RS, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Leung JM, Paul Man SF, Aaron SD, Reed RM, Sin DD; Canadian Respiratory Research Network (CRRN)
doi: 10.1186/s12931-018-0733-z.
RECOMMENDED
COPD
Risk factors for all-cause hospital readmission following exacerbation of COPD: a systematic review and meta-analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
Eur Respir Rev.
Alqahtani JS, Njoku CM, Bereznicki B, Wimmer BC, Peterson GM, Kinsman L, Aldabayan YS, Alrajeh AM, Aldhahir AM, Mandal S, Hurst JR
doi: 10.1183/16000617.0166-2019.
COMMENTED
COPD
Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials
Thorax.
Jolliffe DA, Greenberg L, Hooper RL, Mathyssen C, Rafiq R, de Jongh RT, Camargo CA, Griffiths CJ, Janssens W, Martineau AR
doi: 10.1136/thoraxjnl-2018-212092.
COMMENTED
COPD
Effect of a Program Combining Transitional Care and Long-term Self-management Support on Outcomes of Hospitalized Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial
JAMA.
Aboumatar H, Naqibuddin M, Chung S, Chaudhry H, Kim SW, Saunders J, Bone L, Gurses AP, Knowlton A, Pronovost P, Putcha N, Rand C, Roter D, Sylvester C, Thompson C, Wolff JL, Hibbard J, Wise RA
doi: 10.1001/jama.2018.17933.